SCHEMBL23052291

SCHEMBL23052291

CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 4/20 0.55
CTSK P43235 4/20 0.55
CTSL P07711 2/20 0.55
CTSB P07858 1/20 0.55
ALDH1A1 P00352 2/20 0.49
CAPN1 P07384 1/20 0.48
TDP1 Q9NUW8 3/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 2/20 0.45
FPR2 P25090 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
XBP1 P17861 1/20 0.39
MMP1 P03956 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21248161 0.86 ALDH1A1 (0.53) CTSSCTSKCTSLCTSBALDH1A1
SCHEMBL21248160 0.86 ALDH1A1 (0.53) CTSSCTSKCTSLCTSBALDH1A1
SCHEMBL30365142 0.85 CTSS (0.52) CTSSCTSKCTSLCTSBCAPN1
SCHEMBL23052061 0.85 CTSS (0.52) CTSSCTSKCTSLCTSBCAPN1
SCHEMBL15762019 0.84 CTSK (0.52) CTSSCTSKCTSLCTSBCAPN1
SCHEMBL21248186 0.83 ALDH1A1 (0.50) CTSSCTSKCTSLCTSBALDH1A1
SCHEMBL13489703 0.83 KDM4E (0.47) CTSSCTSKCTSLCTSBMAPT
SCHEMBL29918109 0.83 CTSS (0.60) CTSSCTSKCTSLCTSBCAPN1
SCHEMBL21265876 0.82 ALDH1A1 (0.49) CTSSCTSKCTSLCTSBALDH1A1
SCHEMBL23619297 0.82 ALDH1A1 (0.49) CTSSCTSKCTSLCTSBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021038426-A1 SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-03-04 WO disclosed